Form 4 for CE Celanese Corp
Accepted 2023-05-15 00:00:00 ET · period of report 2023-05-12 · accession 0001306830-23-000092 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-15 | 2023-05-12 | CE | Murray Mark Christopher | SVP - Acetyls | P - Purchase | $101.69 | +1,008 | 11.6K | +10% | +$102.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-12 | P | A | 1,008 | $101.69 | 11,597 | D | — | — | (F1) The reported price in this line is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $101.647 to $101.725. The reporting person will provide to Celanese Corporation (the "Company"), any security holder of the Company, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price. |